Gixmin 400mg Tablet contains Rifaximin, a broad-spectrum, non-absorbable antibiotic primarily used to treat gastrointestinal infections. Rifaximin exerts its antibacterial effect by inhibiting bacterial RNA synthesis, thereby reducing the growth of pathogenic bacteria within the intestinal tract. It is indicated for the treatment of traveler's diarrhea caused by non-invasive strains of Escherichia coli, as well as for the management of hepatic encephalopathy to decrease the risk of recurrent episodes by reducing ammonia-producing gut bacteria. Additionally, Gixmin 400mg is utilized in the treatment of irritable bowel syndrome with diarrhea (IBS-D) and small intestinal bacterial overgrowth (SIBO). Due to its minimal systemic absorption, Rifaximin has a favorable safety profile with limited systemic side effects. The usual dosage varies depending on the indication, and it is essential to follow the prescribed regimen to ensure therapeutic efficacy and minimize resistance development. Common adverse effects may include nausea, abdominal pain, and headache, although these are generally mild and transient. Gixmin 400mg should be used with caution in patients with hypersensitivity to Rifaximin or rifamycin derivatives. It is contraindicated in patients with severe liver impairment. Consultation with a healthcare professional is recommended prior to initiating therapy.